Skip to content

Whispir announces updated guidance for FY22

Headshot of Shannon Brien

Shannon Brien


Share this
24 Nov 2021
2 min read
Abstract black and white image

Following a near record performance in the first quarter of FY22, our people continue to deliver for our customers. 

This was evidenced by the FY22 guidance update that was shared with the market during Whispir’s Annual General Meeting (AGM) earlier today. Key take-outs include:

  • Revenue to grow by 34% and 42% to between $64m and $68m

  • EBITDA, excluding share-based payments, to improve to between negative $13.2 and $11.2m

  • ARR to remain unchanged, increasing by 22% and 31% to between $65.4m and $70m

  • A 70% to 80% increase on FY21 to between $17m and $18m for Research and Development, which continues to be a focus as we enhance our product and build capability - locally and globally

Whispir is well positioned for growth in FY22, predicated by its list of long-term, blue-chip clients. Several new business wins, including a sizeable customer in North America, provides confidence that the sales pipeline is strong, and the product is delivering to meet the changing needs of customers across our core regions of ANZ, Asia, and North America. 

Commenting on the upgraded revenue and EBITDA guidance, Founder and CEO, Jeromy Wells said: 

“This improved forecast performance, in revenue and EBITDA, validates that our strategy is working. Our updated guidance also highlights the valuable role we’re playing in the delivery of COVID specific communications across our install base. Our ‘return to work’ and ‘vaccine roll-out’ campaigns are clearly benefiting our top-line and they also provide an increased opportunity, for up-sell and cross-sell, introducing our platform, and our products, to an expanding customer base.”

For more information about Whispir’s results, view the AGM Presentation or listen to the recording of the CEO’s Address.

Share this

Talk to an expert

Sign up now to talk with and expert and get a free Whispir demo